WuXi Biologics Congratulates MabSpace on FDA Approval of IND for MSB2311

February 26, 2018

Responsive image

SHANGHAI, Feb. 26, 2018 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, congratulates its partner MabSpace Biosciences for FDA Investigational…

Category: Precious Metals